
Sign up to save your podcasts
Or


Discover how their AI technology is revolutionizing drug discovery with Dr. Vimal Mehta, Co-Founder and CEO BioXcel and how this is leading to the approval of their first drug for agitation in bipolar I and II and schizophrenia, and paving the way for new treatments.
By Moira Gunn4.1
2929 ratings
Discover how their AI technology is revolutionizing drug discovery with Dr. Vimal Mehta, Co-Founder and CEO BioXcel and how this is leading to the approval of their first drug for agitation in bipolar I and II and schizophrenia, and paving the way for new treatments.

21,968 Listeners

43,831 Listeners

32,011 Listeners

30,711 Listeners

43,594 Listeners

707 Listeners

6,407 Listeners

30,212 Listeners

125 Listeners

320 Listeners

9,935 Listeners

34 Listeners

18 Listeners

48 Listeners

138 Listeners